It is known that chronic activation of NF-κB through the expression of a constitutively active form of the kinase NF-κB (IKK2) inhibitor beta-subunit, leading to neuroinflammation and decrease in the BDNF level, which correlates with cognitive impairment and neurodegeneration. This evidence concerns the gene BDNF and Cognitive impairment.